Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06366854 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

UK ANDROMEDA-Shock-2 RCT

StatusNot Yet Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Notable Start date: May 1, 2024 to Jul 1, 2024v2
  2. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of the trial is to test if a strategy of resuscitation guided by capillary refill time and individualised clinical hemodynamic phenotyping can improve important clinical outcomes within 28 days in septic shock patients compared to usual care.
Trial Details
NCT Number NCT06366854
Lead Sponsor Guy's and St Thomas' NHS Foundation Trust
Collaborators: Pontificia Universidad Catolica de Chile, University of Rotterdam, The Netherlands
Conditions
(from sponsor)
Septic Shock
Related terms Shock, Septic
Enrollment 25 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov